Risk Factors for Chronic Prostatitis Patients in Northwest China

April 25, 2024 updated by: Shaanxi Provincial People's Hospital

Risk Factors for Chronic Prostatitis/Chronic Pelvic Pain Syndrome Patients in Northwest China

The goal of this observational study is to learn about the risk factors of lifestyle, medication and sexual habits in adult chronic prostatitis / chronic pelvic pain syndrome patients. The main questions it aims to answer are:

  • Is lifestyle, medication, and sexual habits related to chronic prostatitis / chronic pelvic pain syndrome
  • Is there any medication available to protect men from chronic prostatitis / chronic pelvic pain syndrome.

Participants will:

  • Independently receive a survey questionnaire on lifestyle, medication, and sexual habits.
  • Symptomatic individuals will undergo additional prostate fluid examination for diagnosis.

Researchers will compare healthy adult males to see if there are differences on lifestyle, medication and sexual habits between the two groups.

Study Overview

Detailed Description

All participants were asked to fill out a questionnaire which was modified based on Zhang Ran's research. The questionnaire contained the following parts: patient's general situation, dietary habits, disease status, medication, lifestyle, sexual habits and NIH-CPSI index (National Institutes of Health Chronic Prostatitis Symptom Index). Furthermore, the patients underwent digital rectal examination, expressed prostatic secretion microscopy and microbial culture, urinalysis, urine microbial culture and transrectal ultrasonography.

Study Type

Observational

Enrollment (Estimated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Shaanxi
      • Xi'an, Shaanxi, China, 710061
        • Recruiting
        • Shaanxi provincial people's hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

All patients are from Urology Clinic, while all the controls are recruited from the physical examination center of our hospital.

Description

Inclusion Criteria:

  • (1) discomfort or pain in the pelvic region or perineum; (2) symptoms lasting for at least 3 months; and (3) NIH-CPSI pain score of ≥ 4. Controls are volunteers who do not present any prostatitis-related symptoms.

Exclusion Criteria:

  • (1) prostate cancer; (2) benign prostatic hyperplasia with a post-void residual urine volume of >50 ml; (3) acute urinary tract infection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
case group
participates diagnosed with Chronic prostatitis/chronic pelvic pain syndrome
Life habits and personal preferences
Sexual experience and activities
use of medication
control group
participates without Chronic prostatitis/chronic pelvic pain syndrome
Life habits and personal preferences
Sexual experience and activities
use of medication

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Odds Ratio
Time Frame: baseline
The ratio of exposed to unexposed individuals in the case group divided by the ratio of exposed to unexposed individuals in the control group
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Chun Du, Professor, Shaanxi provincial people's hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Estimated)

May 1, 2024

Study Completion (Estimated)

June 1, 2024

Study Registration Dates

First Submitted

April 24, 2024

First Submitted That Met QC Criteria

April 25, 2024

First Posted (Actual)

April 26, 2024

Study Record Updates

Last Update Posted (Actual)

April 26, 2024

Last Update Submitted That Met QC Criteria

April 25, 2024

Last Verified

August 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Prostatitis With Chronic Pelvic Pain Syndrome

Clinical Trials on lifestyle

3
Subscribe